3SBio Inc. clinical trials

The registry lists 106 studies whose lead sponsor is 3SBio Inc. or one of 5 companies grouped under it. 47 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 15, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 106. Browse all 106 →

• SPGL008 in Combination With SSGJ-706 ± Chemotherapy for Advanced Non-small Cell Lung CancerNot yet recruitingNCT07874984Phase 2

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Phase II Study of SSGJ-612 Plus a HER2-Targeted ADC in HR-Positive, HER2-Low or HER2-Ultralow Expression Metastatic Breast CancerRecruitingNCT07757230Phase 2

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• Evaluation of 611 in Chinese Children With Moderate to Severe Atopic Dermatitis(AD)RecruitingNCT07767253Phase 3

  Sponsor listed in the registry: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · First submitted after Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. became part of 3SBio Inc.

• Phase I Clinical Study to Evaluate the Safety and Efficacy of 3SC009 Monotherapy for Patients With Advanced Solid TumorsNot yet recruitingNCT07815002Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UCRecruitingNCT07507513Phase 2

  Sponsor listed in the registry: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · First submitted after Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. became part of 3SBio Inc.

• SSGJ-705 Plus SSGJ-612 ± Chemotherapy in Advanced HER2-Expressing Solid TumorsRecruitingNCT07646626Phase 2

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Study of SSGJ-613 in Gout Participants Initiating Urate-Lowering TreatmentNot yet recruitingNCT07708181Phase 2

  Sponsor listed in the registry: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · First submitted after Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. became part of 3SBio Inc.

• A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic DermatitisRecruitingNCT07693738Phase 1

  Sponsor listed in the registry: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · First submitted after Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. became part of 3SBio Inc.

• A Study of SSS68 Following a Single Subcutaneous Administration in Healthy Adult ParticipantsNot yet recruitingNCT07606976Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of SSS67 in Healthy Adult Participants Via Single Intravenous InfusionNot yet recruitingNCT07487545Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• 1% Clascoterone Cream for the Treatment Acne VulgarisNot yet recruitingNCT07457294Phase 3

  Sponsor listed in the registry: Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. · First submitted after Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. became part of 3SBio Inc.

• Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic AlopeciaRecruitingNCT07080931Phase 3

  Sponsor listed in the registry: Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. · First submitted after Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. became part of 3SBio Inc.

• The Study is to Evaluate the Safety and Tolerability of SPGL008 Alone or in Combination With BCG in the Patients With NMIBC, and to Determine the RP2D of SPGL008 Alone or in Combination With BCG.To Evaluate the Preliminary Efficacy of SPGL008 Alone or in Combination With BCG.Not yet recruitingNCT07445308Phase 1/2

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• Safety, Tolerability, PK and PD of SSS55 in Healthy SubjectsRecruitingNCT07058779Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Phase I Study of SPGL008 in Subjects With Advanced Malignant TumorsRecruitingNCT07038005Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Phase 1 Study of SSGJ-709 in Patients With Advanced Malignant TumorsRecruitingNCT07016490Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Study to Evaluate the Efficacy and Safty of 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)Not yet recruitingNCT07349329Phase 3

  Sponsor listed in the registry: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · First submitted after Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. became part of 3SBio Inc.

• Efficacy and Safety Study of 610 in Patients With Severe AsthmaRecruitingNCT06323213Phase 3

  Sponsor listed in the registry: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · First submitted after Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. became part of 3SBio Inc.

• A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） PatientsRecruitingNCT07171606Phase 2

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS)RecruitingNCT07261644Phase 3

  Sponsor listed in the registry: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · First submitted after Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. became part of 3SBio Inc.

• The Purpose of This Study is to Evaluate the Efficacy and Safety of 626 in the Treatment of SLERecruitingNCT07185269Phase 1/2

  Sponsor listed in the registry: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · First submitted after Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. became part of 3SBio Inc.

• A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal CancersNot yet recruitingNCT07233850Phase 2

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic DermatitisRecruitingNCT07042126Phase 3

  Sponsor listed in the registry: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · First submitted after Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. became part of 3SBio Inc.

• Evaluation of 611 in Chinese Adults Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseRecruitingNCT07039669Phase 3

  Sponsor listed in the registry: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · First submitted after Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. became part of 3SBio Inc.

• SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid TumorsRecruitingNCT07022002Phase 2

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Phase I Study of SSGJ-612 in Patients With Advanced Solid TumorsRecruitingNCT07032298Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• Evaluation of 627 in Healthy Adult SubjectsNot yet recruitingNCT07065136Phase 1

  Sponsor listed in the registry: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · First submitted after Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. became part of 3SBio Inc.

• Phase I Study of HBT-708 for Patients With Advanced Solid TumorsRecruitingNCT06993870Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SSS39 Injection in Healthy Chinese SubjectsEnrolling by invitationNCT07057726Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• Efficacy and Safety of Clascoterone Cream 1% in Facial Acne VulgarisRecruitingNCT06403501Phase 3

  Sponsor listed in the registry: Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. · First submitted after Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. became part of 3SBio Inc.

• A Study of Two Different Formulations of 611 in Healthy Adult Subjects in ChinaNot yet recruitingNCT07042113Phase 1

  Sponsor listed in the registry: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · First submitted after Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. became part of 3SBio Inc.

• A Phase 1 Mass Balance Study of [¹⁴C]SSS17 in Healthy Chinese MalesNot yet recruitingNCT07025915Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• SSGJ-707 in Advanced Non-Small Cell Lung CancerRecruitingNCT06980272Phase 3

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• Phase IIa Trial of Oral SSS17 for Post-Arthroplasty AnemiaNot yet recruitingNCT07007936Phase 2

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer PainRecruitingNCT07008703Phase 1/2

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and HyperuricemiaRecruitingNCT06629376Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Phase I Clinical Study of SSS59 Monotherapy in Patients With Advanced Malignant TumorsRecruitingNCT06944444Phase 1

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)RecruitingNCT06222671Phase 2

  Sponsor listed in the registry: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · First submitted after Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. became part of 3SBio Inc.

• Study of SSS06 for Chemotherapy-Induced Anemia in Non-Myeloid MalignanciesNot yet recruitingNCT06854276Phase 2

  Sponsor listed in the registry: Shenyang Sunshine Pharmaceutical Co., LTD.

• A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer PatientsRecruitingNCT06522828Phase 2

  Sponsor listed in the registry: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · First submitted after Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. became part of 3SBio Inc.

• A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SSGJ-705 Monotherapy in Patients with Advanced Malignant TumorsRecruitingNCT06390774Phase 1

  Sponsor listed in the registry: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · First submitted after Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. became part of 3SBio Inc.

• A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer PatientsRecruitingNCT06493760Phase 2

  Sponsor listed in the registry: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · First submitted after Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. became part of 3SBio Inc.

• A Phase II Study of SSGJ-707 Combination Therapy in Advanced NSCLC PatientsRecruitingNCT06412471Phase 2

  Sponsor listed in the registry: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · First submitted after Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. became part of 3SBio Inc.

• A Phase II Study of SSGJ-707 Monotherapy in First-line PD-L1 Positive Advanced NSCLC PatientsRecruitingNCT06361927Phase 2

  Sponsor listed in the registry: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · First submitted after Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. became part of 3SBio Inc.

• An Phase III Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With PsONot yet recruitingNCT06299982Phase 3

  Sponsor listed in the registry: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · First submitted after Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. became part of 3SBio Inc.

• A Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute GoutNot yet recruitingNCT06169891Phase 3

  Sponsor listed in the registry: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · First submitted after Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. became part of 3SBio Inc.

• The MAD Study of SSGJ-613 in Healthy SubjectsNot yet recruitingNCT05966701Phase 1

  Sponsor listed in the registry: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · First submitted after Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. became part of 3SBio Inc.

• Evaluation of 611 in Combination With Topical Corticosteroid in Participants With Moderate to Severe Atopic DermatitisCompletedNCT06554847Phase 3

  Sponsor listed in the registry: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · First submitted after Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. became part of 3SBio Inc.

• Evaluation of 626 in Healthy Adult SubjectsCompletedNCT06674525Phase 1

  Sponsor listed in the registry: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · First submitted after Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. became part of 3SBio Inc.

• Evaluation of 611 in Chinese Children and Adolescents With Moderate to Severe Atopic DermatitisCompletedNCT06324812Phase 1/2

  Sponsor listed in the registry: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · First submitted after Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. became part of 3SBio Inc.